These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22932397)

  • 1. Activated protein C and septic shock: a propensity-matched cohort study*.
    Rimmer E; Kumar A; Doucette S; Marshall J; Dial S; Gurka D; Dellinger RP; Sharma S; Penner C; Kramer A; Wood K; Ronald J; Kumar A; Turgeon AF; Houston DS; Zarychanski R;
    Crit Care Med; 2012 Nov; 40(11):2974-81. PubMed ID: 22932397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
    Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
    Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intravenous unfractionated heparin and mortality in septic shock.
    Zarychanski R; Doucette S; Fergusson D; Roberts D; Houston DS; Sharma S; Gulati H; Kumar A
    Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
    Funk D; Doucette S; Pisipati A; Dodek P; Marshall JC; Kumar A;
    Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between source of infection and hospital mortality in patients who have septic shock.
    Leligdowicz A; Dodek PM; Norena M; Wong H; Kumar A; Kumar A;
    Am J Respir Crit Care Med; 2014 May; 189(10):1204-13. PubMed ID: 24635548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*.
    Park DW; Chun BC; Kwon SS; Yoon YK; Choi WS; Sohn JW; Peck KR; Kim YS; Choi YH; Choi JY; Kim SI; Eom JS; Kim HY; Cheong HJ; Song YG; Choi HJ; Kim JM; Kim MJ
    Crit Care Med; 2012 Dec; 40(12):3140-5. PubMed ID: 22975891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of therapy with recombinant human activated protein C of critically ill surgical patients with infection complicated by septic shock and multiple organ dysfunction syndrome.
    Barie PS; Hydo LJ; Shou J; Eachempati SR
    Surg Infect (Larchmt); 2011 Dec; 12(6):443-9. PubMed ID: 22185191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: a cohort study in septic shock patients.
    Bilbault P; Lavaux T; Launoy A; Gaub MP; Meyer N; Oudet P; Pottecher T; Jaeger A; Schneider F
    Crit Care Med; 2007 Jan; 35(1):69-75. PubMed ID: 17133181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.
    Nguyen HB; Corbett SW; Steele R; Banta J; Clark RT; Hayes SR; Edwards J; Cho TW; Wittlake WA
    Crit Care Med; 2007 Apr; 35(4):1105-12. PubMed ID: 17334251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of six mortality prediction models in patients admitted with severe sepsis and septic shock to the intensive care unit: a prospective cohort study.
    Arabi Y; Al Shirawi N; Memish Z; Venkatesh S; Al-Shimemeri A
    Crit Care; 2003 Oct; 7(5):R116-22. PubMed ID: 12974979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients.
    O'Brien JM; Lu B; Ali NA; Martin GS; Aberegg SK; Marsh CB; Lemeshow S; Douglas IS
    Crit Care Med; 2007 Feb; 35(2):345-50. PubMed ID: 17205003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of case volume on survival of septic shock in patients with malignancies.
    Zuber B; Tran TC; Aegerter P; Grimaldi D; Charpentier J; Guidet B; Mira JP; Pène F;
    Crit Care Med; 2012 Jan; 40(1):55-62. PubMed ID: 21926606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
    Kumar A; Roberts D; Wood KE; Light B; Parrillo JE; Sharma S; Suppes R; Feinstein D; Zanotti S; Taiberg L; Gurka D; Kumar A; Cheang M
    Crit Care Med; 2006 Jun; 34(6):1589-96. PubMed ID: 16625125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant activated protein C for severe sepsis.
    Martí-Carvajal AJ; Solà I; Lathyris D; Cardona AF
    Cochrane Database Syst Rev; 2012 Mar; (3):CD004388. PubMed ID: 22419295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in neutropenic patients with severe sepsis or septic shock.
    Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
    Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
    Annane D; Timsit JF; Megarbane B; Martin C; Misset B; Mourvillier B; Siami S; Chagnon JL; Constantin JM; Petitpas F; Souweine B; Amathieu R; Forceville X; Charpentier C; Tesnière A; Chastre J; Bohe J; Colin G; Cariou A; Renault A; Brun-Buisson C; Bellissant E;
    Am J Respir Crit Care Med; 2013 May; 187(10):1091-7. PubMed ID: 23525934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.